About Us
Shannon Traphagen
Also known as S.M. Traphagen, Shannon is the host and creator of The Game On Glio Podcast – a top rated national and global podcast, currently ranking in the top 10% of ALL podcasts globally. We have also recently been ranked in Feedspot’s top 80 storytelling podcasts nationally out of thousands of podcasts nationally. It is also an award winner for the 2023 Ignite Awards. Shannon created the podcast in her late husband’s memory to help brain cancer/tumor patients, to spread awareness and advocacy, to educate, and tell the stories and expertise of those on a cancer journey. However the show has now morphed into a hope filled storytelling show that journals rare cancers, second chance love stories, young caregiving, biotech clinical trials, health advocacy and so much more. Shannon was the founder of Traphagen’s Trail Ride 4 Brain Cancer, which ran for four years and raised more than $85,000 for brain cancer clinical trials like SurvaxM smaller non-profits.

With several years experience as a radio personality, grief and loss motivational speaker, and television host, she is also an accomplished writer, and social media influencer. She is the owner of Write Life Media LLC. Her published novel FINDING MORGAN: A LEFAY TRILOGY has received 5-star reviews and is currently available on Amazon. When Shannon is not hosting The Game On Glio Podcast, she does public speaking engagements, helps support brain cancer fundraisers, and handles media projects for global clients. She is currently working on a book about her journey with grief and loss. To learn more about her writing work, visit her website smtraphagen.com
If you’d like to inquire about media and social media services, book a public speaker appearances, or podcast sponsorships, contact her at writelifemediamarketing@gmail.com, gameongliopodcast@gmail.com or via Instagram @gameongliopodcast.

Kevin T. Minorczyk
Kevin is a highly experienced media producer in Buffalo, NY. Working primarily in radio, podcast, and television production, his experience extends to print and web advertising, with specialties in editing and visual effects. He works with WKBW channel 7 news & Write Life Media/The Game On Glio Podcast. Kevin is involved in the 48 Film Project-Buffalo, each year, churning out quality film projects within 48 hours!

Chris Sniezak
Chris has been producing, editing, and hosting podcasts for over a decade. Most of that has been with Misdirected Mark Productions where he’s worked on over 1000 episodes, a dozen different shows, with several of them having been nominated for awards. These days he has the pleasure of working for Write Life Media on The Game on Glio Podcast.
Chris is also a game designer and writer in the tabletop RPG space with Encoded Designs doing everything from game design and writing to marketing and graphic design.
Our Season 5 Premier Sponsors
Gamma Tile Therapy
GT Medical Technologies was founded by a dedicated team of brain tumor specialists to address unmet needs in brain tumor treatment. The company is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care.
About GammaTile
GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile provides immediate, localized treatment. This approach targets remaining cancer cells when they are at their lowest levels to help prevent regrowth, while minimizing radiation exposure to healthy brain tissue.
Since its full market launch in the United States in March 2020, GammaTile has been adopted by more than 100 leading centers, underscoring its growing acceptance in both academic and community healthcare settings. Visit gammatile.com to learn more or follow @GammaTile on Twitter, Facebook and LinkedIn.
Imvax Inc.
Imvax is a clinical-stage biotechnology company with a unique platform technology, Goldspire™, focused on delivering personalized, whole tumor-derived immunotherapies across a range of solid tumors. Imvax’s most advanced program, IGV-001, is currently being evaluated in a Phase 2b clinical trial in newly diagnosed glioblastoma patients (NCT04485949). Imvax’s portfolio also includes several other programs designed to stimulate a patient’s immune system against the entire antigen signature of their tumor. Imvax is headquartered in Philadelphia, PA. For additional information, please visit www.imvax.com and follow @imvax_inc on Twitter and LinkedIn.
Season 5 Episode Sponsors
Plus Therapeutics

Minimum toxicity to healthy cell and maximum toxicity to cancer cells, Plus Therapeutics is power and precision in radiotherapeutics. Radiation is considered one of the most powerful methods of destroying cancer for over a century. But even today, ways to deliver significant doses to a tumor without damaging normal surrounding tissue are few.
Leveraging novel drug formulations and technologies, our drugs are designed to deliver a single, safe and effective dose of radiation directly to the tumor in adults and children battling rare and difficult-to-treat cancers. Our precise approach has the potential to preserve normal cell and tissue functioning – and add more precious moments to each patient’s life. Learn more at plustherapeutics.com
Highmark Blue Cross Blue Shield of WNY
Care that fits your life! Highmark Blue Cross Blue Shield of Western New York has built a legacy around empowering our communities and helping you be your very best you. They offer health plans that provide reliable coverage to Western New Yorkers and by supporting the organizations and individuals who work hard every day to keep our communities healthy. Learn more at https://www.bcbswny.com/
Carthera Advanced Brain Therapy
Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices, like SonoCloud®, to treat a wide range of severe brain disorders. SonoCloud® is an intracranial implant that opens the blood-brain barrier (BBB) before or after the injection of chemotherapy or other therapeutic agents (e.g. immunotherapy). Four minutes of low-intensity pulsed ultrasound (LIPU) opens the BBB for several hours thereby increasing the concentration of therapeutic molecules in the brain.
Learn more at https://carthera.eu/
CYPRIS THERAPEUTICS
Cypris is a chemistry-focused pharmaceutical start-up company based in Syracuse, NY. The technology was created from an industry-academia collaboration between Ichor Life Sciences & Florida State University. Leveraging a proprietary synthetic chemistry and drug development (harnessed from the Cypris Tree), they are creating next generation therapies for unmet clinical needs targeting cancers like brain cancer.
CURTANA PHARMACEUTICALS
Curtana Pharmaceuticals is developing highly targeted therapies for the treatment of brain cancer, including glioblastoma in adults and medulloblastoma in children.
Despite aggressive treatments like surgery, radiation, and chemotherapy, glioblastoma and medulloblastoma patients face poor prognoses. CT-179 aims to change this narrative by inhibiting OLIG2, thereby attacking the root cause of tumor growth and resistance. To learn more about CT-179 or if you are interested in bringing this clinical trial to your hospital, visit curtanapharma.com
